Global Bacterial Vaginosis OTC Drug Market Growth 2021-2026

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Bacterial Vaginosis OTC Drug Consumption 2016-2026

2.1.2 Bacterial Vaginosis OTC Drug Consumption CAGR by Region

2.2 Bacterial Vaginosis OTC Drug Segment by Type

2.2.1 Pill

2.2.2 Gel

2.2.3 Cream

2.2.4 Other

2.3 Bacterial Vaginosis OTC Drug Sales by Type

2.3.1 Global Bacterial Vaginosis OTC Drug Sales Market Share by Type (2016-2021)

2.3.2 Global Bacterial Vaginosis OTC Drug Revenue and Market Share by Type (2016-2021)

2.3.3 Global Bacterial Vaginosis OTC Drug Sale Price by Type (2016-2021)

2.4 Bacterial Vaginosis OTC Drug Segment by Application

2.4.1 Pharmacy

2.4.2 On-line

2.4.3 Other

2.5 Bacterial Vaginosis OTC Drug Sales by Application

2.5.1 Global Bacterial Vaginosis OTC Drug Sale Market Share by Application (2016-2021)

2.5.2 Global Bacterial Vaginosis OTC Drug Revenue and Market Share by Application (2016-2021)

2.5.3 Global Bacterial Vaginosis OTC Drug Sale Price by Application (2016-2021)

3 Global Bacterial Vaginosis OTC Drug by Company

3.1 Global Bacterial Vaginosis OTC Drug Sales Market Share by Company

3.1.1 Global Bacterial Vaginosis OTC Drug Sales by Company (2019-2021)

3.1.2 Global Bacterial Vaginosis OTC Drug Sales Market Share by Company (2019-2021)

3.2 Global Bacterial Vaginosis OTC Drug Revenue Market Share by Company

3.2.1 Global Bacterial Vaginosis OTC Drug Revenue by Company (2019-2021)

3.2.2 Global Bacterial Vaginosis OTC Drug Revenue Market Share by Company (2019-2021)

3.3 Global Bacterial Vaginosis OTC Drug Sale Price by Company

3.4 Global Manufacturers Bacterial Vaginosis OTC Drug Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Bacterial Vaginosis OTC Drug Product Location Distribution

3.4.2 Players Bacterial Vaginosis OTC Drug Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Bacterial Vaginosis OTC Drug by Region

4.1 Global Bacterial Vaginosis OTC Drug by Region

4.1.1 Global Bacterial Vaginosis OTC Drug Sales by Region

4.1.2 Global Bacterial Vaginosis OTC Drug Revenue by Region

4.2 Americas Bacterial Vaginosis OTC Drug Sales Growth

4.3 APAC Bacterial Vaginosis OTC Drug Sales Growth

4.4 Europe Bacterial Vaginosis OTC Drug Sales Growth

4.5 Middle East & Africa Bacterial Vaginosis OTC Drug Sales Growth

5 Americas

5.1 Americas Bacterial Vaginosis OTC Drug Sales by Country

5.1.1 Americas Bacterial Vaginosis OTC Drug Sales by Country (2016-2021)

5.1.2 Americas Bacterial Vaginosis OTC Drug Revenue by Country (2016-2021)

5.2 Americas Bacterial Vaginosis OTC Drug Sales by Type

5.3 Americas Bacterial Vaginosis OTC Drug Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Bacterial Vaginosis OTC Drug Sales by Region

6.1.1 APAC Bacterial Vaginosis OTC Drug Sales by Region (2016-2021)

6.1.2 APAC Bacterial Vaginosis OTC Drug Revenue by Region (2016-2021)

6.2 APAC Bacterial Vaginosis OTC Drug Sales by Type

6.3 APAC Bacterial Vaginosis OTC Drug Sales by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Bacterial Vaginosis OTC Drug by Country

7.1.1 Europe Bacterial Vaginosis OTC Drug Sales by Country (2016-2021)

7.1.2 Europe Bacterial Vaginosis OTC Drug Revenue by Country (2016-2021)

7.2 Europe Bacterial Vaginosis OTC Drug Sales by Type

7.3 Europe Bacterial Vaginosis OTC Drug Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Bacterial Vaginosis OTC Drug by Country

8.1.1 Middle East & Africa Bacterial Vaginosis OTC Drug Sales by Country (2016-2021)

8.1.2 Middle East & Africa Bacterial Vaginosis OTC Drug Revenue by Country (2016-2021)

8.2 Middle East & Africa Bacterial Vaginosis OTC Drug Sales by Type

8.3 Middle East & Africa Bacterial Vaginosis OTC Drug Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Country

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Bacterial Vaginosis OTC Drug Distributors

10.3 Bacterial Vaginosis OTC Drug Customer

11 Global Bacterial Vaginosis OTC Drug Market Forecast

11.1 Global Bacterial Vaginosis OTC Drug Forecast by Region

11.1.1 Global Bacterial Vaginosis OTC Drug Forecast by Regions (2021-2026)

11.2.2 Global Bacterial Vaginosis OTC Drug Revenue Forecast by Regions (2021-2026)

11.2 Americas Forecast by Country

11.3 APAC Forecast by Region

11.4 Europe Forecast by Country

11.5 Middle East & Africa Forecast by Country

11.6 Global Bacterial Vaginosis OTC Drug Forecast by Type

11.7 Global Bacterial Vaginosis OTC Drug Forecast by Application

12 Key Players Analysis

12.1 Bayer

12.1.1 Bayer Company Information

12.1.2 Bayer Bacterial Vaginosis OTC Drug Product Offered

12.1.3 Bayer Bacterial Vaginosis OTC Drug Sales, Revenue, Price and Gross Margin (2019-2021)

12.1.4 Bayer Main Business Overview

12.1.5 Bayer Latest Developments

12.2 Pfizer

12.2.1 Pfizer Company Information

12.2.2 Pfizer Bacterial Vaginosis OTC Drug Product Offered

12.2.3 Pfizer Bacterial Vaginosis OTC Drug Sales, Revenue, Price and Gross Margin (2019-2021)

12.2.4 Pfizer Main Business Overview

12.2.5 Pfizer Latest Developments

12.3 Sanofi

12.3.1 Sanofi Company Information

12.3.2 Sanofi Bacterial Vaginosis OTC Drug Product Offered

12.3.3 Sanofi Bacterial Vaginosis OTC Drug Sales, Revenue, Price and Gross Margin (2019-2021)

12.3.4 Sanofi Main Business Overview

12.3.5 Sanofi Latest Developments

12.4 Piramal

12.4.1 Piramal Company Information

12.4.2 Piramal Bacterial Vaginosis OTC Drug Product Offered

12.4.3 Piramal Bacterial Vaginosis OTC Drug Sales, Revenue, Price and Gross Margin (2019-2021)

12.4.4 Piramal Main Business Overview

12.4.5 Piramal Latest Developments

12.5 Abbott

12.5.1 Abbott Company Information

12.5.2 Abbott Bacterial Vaginosis OTC Drug Product Offered

12.5.3 Abbott Bacterial Vaginosis OTC Drug Sales, Revenue, Price and Gross Margin (2019-2021)

12.5.4 Abbott Main Business Overview

12.5.5 Abbott Latest Developments

12.6 Galderma

12.6.1 Galderma Company Information

12.6.2 Galderma Bacterial Vaginosis OTC Drug Product Offered

12.6.3 Galderma Bacterial Vaginosis OTC Drug Sales, Revenue, Price and Gross Margin (2019-2021)

12.6.4 Galderma Main Business Overview

12.6.5 Galderma Latest Developments

12.7 Mission

12.7.1 Mission Company Information

12.7.2 Mission Bacterial Vaginosis OTC Drug Product Offered

12.7.3 Mission Bacterial Vaginosis OTC Drug Sales, Revenue, Price and Gross Margin (2019-2021)

12.7.4 Mission Main Business Overview

12.7.5 Mission Latest Developments

12.8 Alkem

12.8.1 Alkem Company Information

12.8.2 Alkem Bacterial Vaginosis OTC Drug Product Offered

12.8.3 Alkem Bacterial Vaginosis OTC Drug Sales, Revenue, Price and Gross Margin (2019-2021)

12.8.4 Alkem Main Business Overview

12.8.5 Alkem Latest Developments

12.9 Xiuzheng

12.9.1 Xiuzheng Company Information

12.9.2 Xiuzheng Bacterial Vaginosis OTC Drug Product Offered

12.9.3 Xiuzheng Bacterial Vaginosis OTC Drug Sales, Revenue, Price and Gross Margin (2019-2021)

12.9.4 Xiuzheng Main Business Overview

12.9.5 Xiuzheng Latest Developments

12.10 Teva

12.10.1 Teva Company Information

12.10.2 Teva Bacterial Vaginosis OTC Drug Product Offered

12.10.3 Teva Bacterial Vaginosis OTC Drug Sales, Revenue, Price and Gross Margin (2019-2021)

12.10.4 Teva Main Business Overview

12.10.5 Teva Latest Developments

12.11 Perrigo

12.11.1 Perrigo Company Information

12.11.2 Perrigo Bacterial Vaginosis OTC Drug Product Offered

12.11.3 Perrigo Bacterial Vaginosis OTC Drug Sales, Revenue, Price and Gross Margin (2019-2021)

12.11.4 Perrigo Main Business Overview

12.11.5 Perrigo Latest Developments

12.12 West-Ward

12.12.1 West-Ward Company Information

12.12.2 West-Ward Bacterial Vaginosis OTC Drug Product Offered

12.12.3 West-Ward Bacterial Vaginosis OTC Drug Sales, Revenue, Price and Gross Margin (2019-2021)

12.12.4 West-Ward Main Business Overview

12.12.5 West-Ward Latest Developments

12.13 HPGC

12.13.1 HPGC Company Information

12.13.2 HPGC Bacterial Vaginosis OTC Drug Product Offered

12.13.3 HPGC Bacterial Vaginosis OTC Drug Sales, Revenue, Price and Gross Margin (2019-2021)

12.13.4 HPGC Main Business Overview

12.13.5 HPGC Latest Developments

12.14 Yunnan Baiyao

12.14.1 Yunnan Baiyao Company Information

12.14.2 Yunnan Baiyao Bacterial Vaginosis OTC Drug Product Offered

12.14.3 Yunnan Baiyao Bacterial Vaginosis OTC Drug Sales, Revenue, Price and Gross Margin (2019-2021)

12.14.4 Yunnan Baiyao Main Business Overview

12.14.5 Yunnan Baiyao Latest Developments

12.15 Starpharma

12.15.1 Starpharma Company Information

12.15.2 Starpharma Bacterial Vaginosis OTC Drug Product Offered

12.15.3 Starpharma Bacterial Vaginosis OTC Drug Sales, Revenue, Price and Gross Margin (2019-2021)

12.15.4 Starpharma Main Business Overview

12.15.5 Starpharma Latest Developments

12.16 Novel

12.16.1 Novel Company Information

12.16.2 Novel Bacterial Vaginosis OTC Drug Product Offered

12.16.3 Novel Bacterial Vaginosis OTC Drug Sales, Revenue, Price and Gross Margin (2019-2021)

12.16.4 Novel Main Business Overview

12.16.5 Novel Latest Developments

12.17 Edenvridge

12.17.1 Edenvridge Company Information

12.17.2 Edenvridge Bacterial Vaginosis OTC Drug Product Offered

12.17.3 Edenvridge Bacterial Vaginosis OTC Drug Sales, Revenue, Price and Gross Margin (2019-2021)

12.17.4 Edenvridge Main Business Overview

12.17.5 Edenvridge Latest Developments

13 Research Findings and Conclusion

Table 1. Bacterial Vaginosis OTC Drug Consumption CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of Pill

Table 3. Major Players of Gel

Table 4. Major Players of Cream

Table 5. Major Players of Other

Table 6. Global Bacterial Vaginosis OTC Drug Sales by Type (2016-2021) & (K Units)

Table 7. Global Bacterial Vaginosis OTC Drug Sales Market Share by Type (2016-2021)

Table 8. Global Bacterial Vaginosis OTC Drug Revenue by Type (2016-2021) & ($ million)

Table 9. Global Bacterial Vaginosis OTC Drug Revenue Market Share by Type (2016-2021)

Table 10. Global Bacterial Vaginosis OTC Drug Sale Price by Type (2016-2021)

Table 11. Global Bacterial Vaginosis OTC Drug Sales by Application (2016-2021) & (K Units)

Table 12. Global Bacterial Vaginosis OTC Drug Sales Market Share by Application (2016-2021)

Table 13. Global Bacterial Vaginosis OTC Drug Value by Application (2016-2021)

Table 14. Global Bacterial Vaginosis OTC Drug Revenue Market Share by Application (2016-2021)

Table 15. Global Bacterial Vaginosis OTC Drug Sale Price by Application (2016-2021)

Table 16. Global Bacterial Vaginosis OTC Drug Sales by Company (2019-2021) & (K Units)

Table 17. Global Bacterial Vaginosis OTC Drug Sales Market Share by Company (2019-2021)

Table 18. Global Bacterial Vaginosis OTC Drug Revenue by Company (2019-2021) ($ Millions)

Table 19. Global Bacterial Vaginosis OTC Drug Revenue Market Share by Company (2019-2021)

Table 20. Global Bacterial Vaginosis OTC Drug Sale Price by Company (2019-2021)

Table 21. Key Manufacturers Bacterial Vaginosis OTC Drug Producing Area Distribution and Sales Area

Table 22. Players Bacterial Vaginosis OTC Drug Products Offered

Table 23. Bacterial Vaginosis OTC Drug Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Bacterial Vaginosis OTC Drug Sales by Region (2016-2021) (K Units)

Table 27. Global Bacterial Vaginosis OTC Drug Sales Market Share by Region (2016-2021)

Table 28. Global Bacterial Vaginosis OTC Drug Revenue by Region (2016-2021) & ($ Millions)

Table 29. Global Bacterial Vaginosis OTC Drug Revenue Market Share by Region (2016-2021)

Table 30. Americas Bacterial Vaginosis OTC Drug Sales by Country (2016-2021) & (K Units)

Table 31. Americas Bacterial Vaginosis OTC Drug Sales Market Share by Country (2016-2021)

Table 32. Americas Bacterial Vaginosis OTC Drug Revenue by Country (2016-2021) & ($ Millions)

Table 33. Americas Bacterial Vaginosis OTC Drug Revenue Market Share by Country (2016-2021)

Table 34. Americas Bacterial Vaginosis OTC Drug Sales by Type (2016-2021) & (K Units)

Table 35. Americas Bacterial Vaginosis OTC Drug Sales Market Share by Type (2016-2021)

Table 36. Americas Bacterial Vaginosis OTC Drug Sales by Application (2016-2021) & (K Units)

Table 37. Americas Bacterial Vaginosis OTC Drug Sales Market Share by Application (2016-2021)

Table 38. APAC Bacterial Vaginosis OTC Drug Sales by Region (2016-2021) & (K Units)

Table 39. APAC Bacterial Vaginosis OTC Drug Sales Market Share by Region (2016-2021)

Table 40. APAC Bacterial Vaginosis OTC Drug Revenue by Region (2016-2021) & ($ Millions)

Table 41. APAC Bacterial Vaginosis OTC Drug Revenue Market Share by Region (2016-2021)

Table 42. APAC Bacterial Vaginosis OTC Drug Sales by Type (2016-2021) & (K Units)

Table 43. APAC Bacterial Vaginosis OTC Drug Sales Market Share by Type (2016-2021)

Table 44. APAC Bacterial Vaginosis OTC Drug Sales by Application (2016-2021) & (K Units)

Table 45. APAC Bacterial Vaginosis OTC Drug Sales Market Share by Application (2016-2021)

Table 46. Europe Bacterial Vaginosis OTC Drug Sales by Country (2016-2021) & (K Units)

Table 47. Europe Bacterial Vaginosis OTC Drug Sales Market Share by Country (2016-2021)

Table 48. Europe Bacterial Vaginosis OTC Drug Revenue by Country (2016-2021) & ($ Millions)

Table 49. Europe Bacterial Vaginosis OTC Drug Revenue Market Share by Country (2016-2021)

Table 50. Europe Bacterial Vaginosis OTC Drug Sales by Type (2016-2021) & (K Units)

Table 51. Europe Bacterial Vaginosis OTC Drug Sales Market Share by Type (2016-2021)

Table 52. Europe Bacterial Vaginosis OTC Drug Sales by Application (2016-2021) & (K Units)

Table 53. Europe Bacterial Vaginosis OTC Drug Sales Market Share by Application (2016-2021)

Table 54. Middle East & Africa Bacterial Vaginosis OTC Drug Sales by Country (2016-2021) & (K Units)

Table 55. Middle East & Africa Bacterial Vaginosis OTC Drug Sales Market Share by Country (2016-2021)

Table 56. Middle East & Africa Bacterial Vaginosis OTC Drug Revenue by Country (2016-2021) & ($ Millions)

Table 57. Middle East & Africa Bacterial Vaginosis OTC Drug Revenue Market Share by Country (2016-2021)

Table 58. Middle East & Africa Bacterial Vaginosis OTC Drug Sales by Type (2016-2021) & (K Units)

Table 59. Middle East & Africa Bacterial Vaginosis OTC Drug Sales Market Share by Type (2016-2021)

Table 60. Middle East & Africa Bacterial Vaginosis OTC Drug Sales by Application (2016-2021) & (K Units)

Table 61. Middle East & Africa Bacterial Vaginosis OTC Drug Sales Market Share by Application (2016-2021)

Table 62. Key and Potential Regions of Bacterial Vaginosis OTC Drug

Table 63. Key Application and Potential Industries of Bacterial Vaginosis OTC Drug

Table 64. Key Challenges of Bacterial Vaginosis OTC Drug

Table 65. Key Trends of Bacterial Vaginosis OTC Drug

Table 66. Bacterial Vaginosis OTC Drug Distributors List

Table 67. Bacterial Vaginosis OTC Drug Customer List

Table 68. Global Bacterial Vaginosis OTC Drug Sales Forecast by Region (2021-2026) & (K Units)

Table 69. Global Bacterial Vaginosis OTC Drug Consumption Market Forecast by Region

Table 70. Global Bacterial Vaginosis OTC Drug Revenue Forecast by Region (2021-2026) & ($ millions)

Table 71. Global Bacterial Vaginosis OTC Drug Revenue Market Share Forecast by Region (2021-2026)

Table 72. Americas Bacterial Vaginosis OTC Drug Sales Forecast by Country (2021-2026) & (K Units)

Table 73. Americas Bacterial Vaginosis OTC Drug Revenue Forecast by Country (2021-2026) & ($ millions)

Table 74. APAC Bacterial Vaginosis OTC Drug Sales Forecast by Region (2021-2026) & (K Units)

Table 75. APAC Bacterial Vaginosis OTC Drug Revenue Forecast by Region (2021-2026) & ($ millions)

Table 76. Europe Bacterial Vaginosis OTC Drug Sales Forecast by Country (2021-2026) & (K Units)

Table 77. Europe Bacterial Vaginosis OTC Drug Revenue Forecast by Country (2021-2026) & ($ millions)

Table 78. Middle East & Africa Bacterial Vaginosis OTC Drug Sales Forecast by Country (2021-2026) & (K Units)

Table 79. Middle East & Africa Bacterial Vaginosis OTC Drug Revenue Forecast by Country (2021-2026) & ($ millions)

Table 80. Global Bacterial Vaginosis OTC Drug Sales Forecast by Type (2021-2026) & (K Units)

Table 81. Global Bacterial Vaginosis OTC Drug Sales Market Share Forecast by Type (2021-2026)

Table 82. Global Bacterial Vaginosis OTC Drug Revenue Forecast by Type (2021-2026) & ($ Millions)

Table 83. Global Bacterial Vaginosis OTC Drug Revenue Market Share Forecast by Type (2021-2026)

Table 84. Global Bacterial Vaginosis OTC Drug Sales Forecast by Application (2021-2026) & (K Units)

Table 85. Global Bacterial Vaginosis OTC Drug Sales Market Share Forecast by Application (2021-2026)

Table 86. Global Bacterial Vaginosis OTC Drug Revenue Forecast by Application (2021-2026) & ($ Millions)

Table 87. Global Bacterial Vaginosis OTC Drug Revenue Market Share Forecast by Application (2021-2026)

Table 88. Bayer Basic Information, Bacterial Vaginosis OTC Drug Manufacturing Base, Sales Area and Its Competitors

Table 89. Bayer Bacterial Vaginosis OTC Drug Product Offered

Table 90. Bayer Bacterial Vaginosis OTC Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 91. Bayer Main Business

Table 92. Bayer Latest Developments

Table 93. Pfizer Basic Information, Bacterial Vaginosis OTC Drug Manufacturing Base, Sales Area and Its Competitors

Table 94. Pfizer Bacterial Vaginosis OTC Drug Product Offered

Table 95. Pfizer Bacterial Vaginosis OTC Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 96. Pfizer Main Business

Table 97. Pfizer Latest Developments

Table 98. Sanofi Basic Information, Bacterial Vaginosis OTC Drug Manufacturing Base, Sales Area and Its Competitors

Table 99. Sanofi Bacterial Vaginosis OTC Drug Product Offered

Table 100. Sanofi Bacterial Vaginosis OTC Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 101. Sanofi Main Business

Table 102. Sanofi Latest Developments

Table 103. Piramal Basic Information, Bacterial Vaginosis OTC Drug Manufacturing Base, Sales Area and Its Competitors

Table 104. Piramal Bacterial Vaginosis OTC Drug Product Offered

Table 105. Piramal Bacterial Vaginosis OTC Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 106. Piramal Main Business

Table 107. Piramal Latest Developments

Table 108. Abbott Basic Information, Bacterial Vaginosis OTC Drug Manufacturing Base, Sales Area and Its Competitors

Table 109. Abbott Bacterial Vaginosis OTC Drug Product Offered

Table 110. Abbott Bacterial Vaginosis OTC Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 111. Abbott Main Business

Table 112. Abbott Latest Developments

Table 113. Galderma Basic Information, Bacterial Vaginosis OTC Drug Manufacturing Base, Sales Area and Its Competitors

Table 114. Galderma Bacterial Vaginosis OTC Drug Product Offered

Table 115. Galderma Bacterial Vaginosis OTC Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 116. Galderma Main Business

Table 117. Galderma Latest Developments

Table 118. Mission Basic Information, Bacterial Vaginosis OTC Drug Manufacturing Base, Sales Area and Its Competitors

Table 119. Mission Bacterial Vaginosis OTC Drug Product Offered

Table 120. Mission Bacterial Vaginosis OTC Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 121. Mission Main Business

Table 122. Mission Latest Developments

Table 123. Alkem Basic Information, Bacterial Vaginosis OTC Drug Manufacturing Base, Sales Area and Its Competitors

Table 124. Alkem Bacterial Vaginosis OTC Drug Product Offered

Table 125. Alkem Bacterial Vaginosis OTC Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 126. Alkem Main Business

Table 127. Alkem Latest Developments

Table 128. Xiuzheng Basic Information, Bacterial Vaginosis OTC Drug Manufacturing Base, Sales Area and Its Competitors

Table 129. Xiuzheng Bacterial Vaginosis OTC Drug Product Offered

Table 130. Xiuzheng Bacterial Vaginosis OTC Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 131. Xiuzheng Main Business

Table 132. Xiuzheng Latest Developments

Table 133. Teva Basic Information, Bacterial Vaginosis OTC Drug Manufacturing Base, Sales Area and Its Competitors

Table 134. Teva Bacterial Vaginosis OTC Drug Product Offered

Table 135. Teva Bacterial Vaginosis OTC Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 136. Teva Main Business

Table 137. Teva Latest Developments

Table 138. Perrigo Basic Information, Bacterial Vaginosis OTC Drug Manufacturing Base, Sales Area and Its Competitors

Table 139. Perrigo Bacterial Vaginosis OTC Drug Product Offered

Table 140. Perrigo Bacterial Vaginosis OTC Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 141. Perrigo Main Business

Table 142. Perrigo Latest Developments

Table 143. West-Ward Basic Information, Bacterial Vaginosis OTC Drug Manufacturing Base, Sales Area and Its Competitors

Table 144. West-Ward Bacterial Vaginosis OTC Drug Product Offered

Table 145. West-Ward Bacterial Vaginosis OTC Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 146. West-Ward Main Business

Table 147. West-Ward Latest Developments

Table 148. HPGC Basic Information, Bacterial Vaginosis OTC Drug Manufacturing Base, Sales Area and Its Competitors

Table 149. HPGC Bacterial Vaginosis OTC Drug Product Offered

Table 150. HPGC Bacterial Vaginosis OTC Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 151. HPGC Main Business

Table 152. HPGC Latest Developments

Table 153. Yunnan Baiyao Basic Information, Bacterial Vaginosis OTC Drug Manufacturing Base, Sales Area and Its Competitors

Table 154. Yunnan Baiyao Bacterial Vaginosis OTC Drug Product Offered

Table 155. Yunnan Baiyao Bacterial Vaginosis OTC Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 156. Yunnan Baiyao Main Business

Table 157. Yunnan Baiyao Latest Developments

Table 158. Starpharma Basic Information, Bacterial Vaginosis OTC Drug Manufacturing Base, Sales Area and Its Competitors

Table 159. Starpharma Bacterial Vaginosis OTC Drug Product Offered

Table 160. Starpharma Bacterial Vaginosis OTC Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 161. Starpharma Main Business

Table 162. Starpharma Latest Developments

Table 163. Novel Basic Information, Bacterial Vaginosis OTC Drug Manufacturing Base, Sales Area and Its Competitors

Table 164. Novel Bacterial Vaginosis OTC Drug Product Offered

Table 165. Novel Bacterial Vaginosis OTC Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 166. Novel Main Business

Table 167. Novel Latest Developments

Table 168. Edenvridge Basic Information, Bacterial Vaginosis OTC Drug Manufacturing Base, Sales Area and Its Competitors

Table 169. Edenvridge Bacterial Vaginosis OTC Drug Product Offered

Table 170. Edenvridge Bacterial Vaginosis OTC Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 171. Edenvridge Main Business

Table 172. Edenvridge Latest Developments

List of Figures

Figure 1. Picture of Bacterial Vaginosis OTC Drug

Figure 2. Bacterial Vaginosis OTC Drug Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Bacterial Vaginosis OTC Drug Sales Growth Rate 2016-2026 (K Units)

Figure 7. Global Bacterial Vaginosis OTC Drug Revenue Growth Rate 2016-2026 ($ Millions)

Figure 8. Bacterial Vaginosis OTC Drug Sales by Region (2021 & 2026) & ($ millions)

Figure 9. Product Picture of Pill

Figure 10. Product Picture of Gel

Figure 11. Product Picture of Cream

Figure 12. Product Picture of Other

Figure 13. Global Bacterial Vaginosis OTC Drug Sales Market Share by Type in 2020

Figure 14. Global Bacterial Vaginosis OTC Drug Revenue Market Share by Type (2016-2021)

Figure 15. Bacterial Vaginosis OTC Drug Consumed in Pharmacy

Figure 16. Global Bacterial Vaginosis OTC Drug Market: Pharmacy (2016-2021) & (K Units)

Figure 17. Bacterial Vaginosis OTC Drug Consumed in On-line

Figure 18. Global Bacterial Vaginosis OTC Drug Market: On-line (2016-2021) & (K Units)

Figure 19. Bacterial Vaginosis OTC Drug Consumed in Other

Figure 20. Global Bacterial Vaginosis OTC Drug Market: Other (2016-2021) & (K Units)

Figure 21. Global Bacterial Vaginosis OTC Drug Sales Market Share by Application (2016-2021)

Figure 22. Global Bacterial Vaginosis OTC Drug Revenue Market Share by Application in 2020

Figure 23. Bacterial Vaginosis OTC Drug Revenue Market by Company in 2020 ($ Million)

Figure 24. Global Bacterial Vaginosis OTC Drug Revenue Market Share by Company in 2020

Figure 25. Global Bacterial Vaginosis OTC Drug Sales Market Share by Regions (2016-2021)

Figure 26. Global Bacterial Vaginosis OTC Drug Revenue Market Share by Region in 2020

Figure 27. Americas Bacterial Vaginosis OTC Drug Sales 2016-2021 (K Units)

Figure 28. Americas Bacterial Vaginosis OTC Drug Revenue 2016-2021 ($ Millions)

Figure 29. APAC Bacterial Vaginosis OTC Drug Sales 2016-2021 (K Units)

Figure 30. APAC Bacterial Vaginosis OTC Drug Revenue 2016-2021 ($ Millions)

Figure 31. Europe Bacterial Vaginosis OTC Drug Sales 2016-2021 (K Units)

Figure 32. Europe Bacterial Vaginosis OTC Drug Revenue 2016-2021 ($ Millions)

Figure 33. Middle East & Africa Bacterial Vaginosis OTC Drug Sales 2016-2021 (K Units)

Figure 34. Middle East & Africa Bacterial Vaginosis OTC Drug Revenue 2016-2021 ($ Millions)

Figure 35. Americas Bacterial Vaginosis OTC Drug Sales Market Share by Country in 2020

Figure 36. Americas Bacterial Vaginosis OTC Drug Revenue Market Share by Country in 2020

Figure 37. Americas Bacterial Vaginosis OTC Drug Sales Market Share by Type in 2020

Figure 38. Americas Bacterial Vaginosis OTC Drug Sales Market Share by Application in 2020

Figure 39. United States Bacterial Vaginosis OTC Drug Revenue Growth 2016-2021 ($ Millions)

Figure 40. Canada Bacterial Vaginosis OTC Drug Revenue Growth 2016-2021 ($ Millions)

Figure 41. Mexico Bacterial Vaginosis OTC Drug Revenue Growth 2016-2021 ($ Millions)

Figure 42. Brazil Bacterial Vaginosis OTC Drug Revenue Growth 2016-2021 ($ Millions)

Figure 43. APAC Bacterial Vaginosis OTC Drug Sales Market Share by Region in 2020

Figure 44. APAC Bacterial Vaginosis OTC Drug Revenue Market Share by Regions in 2020

Figure 45. APAC Bacterial Vaginosis OTC Drug Sales Market Share by Type in 2020

Figure 46. APAC Bacterial Vaginosis OTC Drug Sales Market Share by Application in 2020

Figure 47. China Bacterial Vaginosis OTC Drug Revenue Growth 2016-2021 ($ Millions)

Figure 48. Japan Bacterial Vaginosis OTC Drug Revenue Growth 2016-2021 ($ Millions)

Figure 49. Korea Bacterial Vaginosis OTC Drug Revenue Growth 2016-2021 ($ Millions)

Figure 50. Southeast Asia Bacterial Vaginosis OTC Drug Revenue Growth 2016-2021 ($ Millions)

Figure 51. India Bacterial Vaginosis OTC Drug Revenue Growth 2016-2021 ($ Millions)

Figure 52. Australia Bacterial Vaginosis OTC Drug Revenue Growth 2016-2021 ($ Millions)

Figure 53. Europe Bacterial Vaginosis OTC Drug Sales Market Share by Country in 2020

Figure 54. Europe Bacterial Vaginosis OTC Drug Revenue Market Share by Country in 2020

Figure 55. Europe Bacterial Vaginosis OTC Drug Sales Market Share by Type in 2020

Figure 56. Europe Bacterial Vaginosis OTC Drug Sales Market Share by Application in 2020

Figure 57. Germany Bacterial Vaginosis OTC Drug Revenue Growth 2016-2021 ($ Millions)

Figure 58. France Bacterial Vaginosis OTC Drug Revenue Growth 2016-2021 ($ Millions)

Figure 59. UK Bacterial Vaginosis OTC Drug Revenue Growth 2016-2021 ($ Millions)

Figure 60. Italy Bacterial Vaginosis OTC Drug Revenue Growth 2016-2021 ($ Millions)

Figure 61. Russia Bacterial Vaginosis OTC Drug Revenue Growth 2016-2021 ($ Millions)

Figure 62. Middle East & Africa Bacterial Vaginosis OTC Drug Sales Market Share by Country in 2020

Figure 63. Middle East & Africa Bacterial Vaginosis OTC Drug Revenue Market Share by Country in 2020

Figure 64. Middle East & Africa Bacterial Vaginosis OTC Drug Sales Market Share by Type in 2020

Figure 65. Middle East & Africa Bacterial Vaginosis OTC Drug Sales Market Share by Application in 2020

Figure 66. Egypt Bacterial Vaginosis OTC Drug Revenue Growth 2016-2021 ($ Millions)

Figure 67. South Africa Bacterial Vaginosis OTC Drug Revenue Growth 2016-2021 ($ Millions)

Figure 68. Israel Bacterial Vaginosis OTC Drug Revenue Growth 2016-2021 ($ Millions)

Figure 69. Turkey Bacterial Vaginosis OTC Drug Revenue Growth 2016-2021 ($ Millions)

Figure 70. GCC Country Bacterial Vaginosis OTC Drug Revenue Growth 2016-2021 ($ Millions)

Figure 71. Channels of Distribution

Figure 72. Distributors Profiles